Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
70.56
-1.45 (-2.01%)
Jul 11, 2025, 4:26 AM - Market open

Corcept Therapeutics Market Cap

Corcept Therapeutics has a market cap or net worth of $7.48 billion as of July 11, 2025. Its market cap has increased by 134.94% in one year.

Market Cap
7.48B
Enterprise Value
7.07B
1-Year Change
134.94%
Ranking
Category
Stock Price
$70.56

Market Cap Chart

Since April 14, 2004, Corcept Therapeutics's market cap has increased from $283.00M to $7.48B, an increase of 2,544.00%. That is a compound annual growth rate of 16.66%.

History

DateMarket Cap% Change
Jul 10, 2025 7.64B 44.64%
Dec 31, 2024 5.28B 57.69%
Dec 29, 2023 3.35B 53.13%
Dec 30, 2022 2.19B -4.35%
Dec 31, 2021 2.29B -24.78%
Dec 31, 2020 3.04B 119.78%
Dec 31, 2019 1.38B -10.36%
Dec 31, 2018 1.54B -25.15%
Dec 29, 2017 2.06B 155.69%
Dec 30, 2016 806.10M 48.81%
Dec 31, 2015 541.70M 78.43%
Dec 31, 2014 303.60M -5.24%
Dec 31, 2013 320.40M 124.53%
Dec 31, 2012 142.70M -50.47%
Dec 30, 2011 288.10M 3.11%
Dec 31, 2010 279.40M 60.85%
Dec 31, 2009 173.70M 248.10%
Dec 31, 2008 49.90M -59.17%
Dec 31, 2007 122.20M 336.43%
Dec 29, 2006 28.00M -66.22%
Dec 30, 2005 82.90M -41.54%
Dec 31, 2004 141.80M -49.89%
View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 698.13B
Johnson & Johnson 374.84B
AbbVie 335.21B
Novo Nordisk 313.36B
UnitedHealth Group 279.13B
Novartis AG 240.15B
Abbott Laboratories 232.02B
AstraZeneca 217.48B
Market Cap Rankings